James Mullen Net Worth

The estimated Net Worth of James C Mullen is at least $48.5 Million dollars as of 3 January 2022. Mr. Mullen owns over 18,252 units of Thermo Fisher Scientific stock worth over $46,939,877 and over the last 21 years he sold TMO stock worth over $1,276,951. In addition, he makes $320,615 as Independent Director at Thermo Fisher Scientific.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Mullen TMO stock SEC Form 4 insiders trading

James has made over 60 trades of the Thermo Fisher Scientific stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 18,252 units of TMO stock worth $491,891 on 3 January 2022.

The largest trade he's ever made was exercising 300,000 units of Thermo Fisher Scientific stock on 16 November 2006 worth over $10,782,000. On average, James trades about 7,606 units every 58 days since 2003. As of 3 January 2022 he still owns at least 75,898 units of Thermo Fisher Scientific stock.

You can see the complete history of Mr. Mullen stock trades at the bottom of the page.

James Mullen biography

James C. Mullen serves as Independent Director of the Company. Mr. Mullen brings valuable industry knowledge to the Board, due to his 35 years of extensive management experience and his senior leadership background in the pharmaceutical and biotechnology industries. Mr. Mullen served as Chief Executive Officer of Patheon, a pharmaceutical contract development and manufacturing organization, prior to its acquisition by the Company in 2017, and as Chief Executive Officer of Biogen, Inc. Mr. Mullen also brings valuable board-level experience from his service on the boards of public companies in the pharmaceutical industry, including his service on various committees, such as the Compensation and Nominating and Corporate Governance Committees.

What is the salary of James Mullen?

As the Independent Director of Thermo Fisher Scientific, the total compensation of James Mullen at Thermo Fisher Scientific is $320,615. There are 20 executives at Thermo Fisher Scientific getting paid more, with Marc Casper having the highest compensation of $19,023,100.

How old is James Mullen?

James Mullen is 61, he's been the Independent Director of Thermo Fisher Scientific since 2018. There are 7 older and 19 younger executives at Thermo Fisher Scientific. The oldest executive at Thermo Fisher Scientific Inc. is Elaine Ullian, 71, who is the Independent Director.

Insiders trading at Thermo Fisher Scientific

Over the last 21 years, insiders at Thermo Fisher Scientific have traded over $356,502,416 worth of Thermo Fisher Scientific stock and bought 4,301 units worth $223,007 . The most active insiders traders include Thomas J Lynch, Dion J Weisler, and Marc N Casper. On average, Thermo Fisher Scientific executives and independent directors trade stock every 23 days with the average trade being worth of $16,400,322. The most recent stock trade was executed by Marc N Casper on 3 September 2024, trading 20,000 units of TMO stock currently worth $4,213,600.

What does Thermo Fisher Scientific do?

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. 

Complete history of Mr. Mullen stock trades at Biogen Inc, Editas Medicine Inc, Insulet, Revvity, and Thermo Fisher Scientific

Thermo Fisher Scientific executives and stock owners

Thermo Fisher Scientific executives and other stock owners filed with the SEC include:

• Marc Casper,
  Chairman of the Board, President, Chief Executive Officer
• Marc N. Casper,
  Chairman, Pres & CEO
• Mark Stevenson,
  Chief Operating Officer, Executive Vice President
• Michel Lagarde,
  Executive Vice President
• Stephen Williamson,
  Chief Financial Officer, Senior Vice President
• Mark P. Stevenson,
  Exec. VP
• Syed Jafry,
  Senior Vice President and President, Regions
• Stephen Williamson,
  Sr. VP & CFO
• Syed A. Jafry,
  Sr. VP & Pres of Regions
• Gianluca Pettiti,
  Exec. VP
• Jim Manzi,
  Independent Director
• Nelson Chai,
  Independent Director
• Judy Lewent,
  Independent Director
• Tyler Jacks,
  Independent Director
• Thomas Lynch,
  Lead Independent Director
• Scott Sperling,
  Independent Director
• Elaine Ullian,
  Independent Director
• Lars Sorensen,
  Independent Director
• C. Martin Harris,
  Independent Director
• Dion Weisler,
  Independent Director
• James Mullen,
  Independent Director
• Debora Spar,
  Independent Director
• R. Alexandra Keith,
  Director
• Kenneth Apicerno,
  Vice President- Investor Relations
• Peter Hornstra,
  Vice President, Chief Accounting Officer
• Michael Boxer,
  Senior Vice President, General Counsel
• Sandy B. Pound,
  VP & Chief Communications Officer
• Michael A. Boxer Esq.,
  Sr. VP & Gen. Counsel
• Rafael Tejada,
  VP of Investor Relations
• Dr. Karen E. Nelson Ph.D.,
  Chief Scientific Officer
• Ryan J. Snyder,
  Sr. VP & Chief Information Officer
• Joseph R. Holmes,
  VP & Chief Accounting Officer
• William G Parrett,
  Director
• Daniel P Shine,
  Senior Vice President
• Thomas W Loewald,
  Senior Vice President
• Seth H Hoogasian,
  VP, Gen. Counsel & Secretary
• Patrick M Durbin,
  Senior Vice President
• Gregory J. Herrema,
  Senior Vice President
• Andrew J Thomson,
  Senior Vice President
• Edward A Pesicka,
  Senior Vice President
• Alan J Malus,
  Senior Vice President
• Kenneth Berger,
  Senior Vice President
• Michael E Porter,
  Director
• Peter J Manning,
  Director
• Yuh Geng Tsay,
  Senior Vice President
• Stephen P Kaufman,
  Director
• Michael Adam Bell,
  Director
• Bruce L Koepfgen,
  Director
• Stephen G Sheehan,
  VP, Human Resources
• Marijn E Dekkers,
  Chief Executive Officer
• Fredric T Walder,
  Sr. VP, Commercial Excellence
• Peter M Wilver,
  VP, Financial Operations
• Guy Broadbent,
  VP, Optical Technologies
• Alexander G Stachtiaris,
  Sr. VP, Global Bus. Services
• Joseph R Massaro,
  Sr. VP, Global Bus. Services
• Paul M Meister,
  Director
• Robert A Mccabe,
  Director
• Leary Robert O,
  Director
• John L Lamattina,
  Director
• Kyriazi Theo Melas,
  VP & Chief Financial Officer
• Richard F/Ca Syron,
  Executive Chairman
• Barry S Howe,
  VP, Measurement & Control
• Joseph R. Holmes,
  VP & Chief Accounting Officer
• Gianluca Pettiti,
  Executive Vice President
• Ruby R Chandy,
  Director
• Lisa P. Britt,
  Sr. VP and Chief HR Officer
• Jennifer M Johnson,
  Director
• Michael D Shafer,
  Executive Vice President
• Frederick M. Lowery,
  Executive Vice President